Five years of therapy with donor and 3rd party derived EBV and CMV specific cytotoxic T cells - Safety after more than 1,000 infusions Meeting Abstract


Authors: Prockop, S.; Doubrovina, E.; Hasan, A.; Koehne, G.; Dahi, P.; Papadopoulos, E.; Sauter, C.; Rodriguez-Sanchez, I.; Suser, S.; Escobedo, V.; Szenes, V.; O'Reilly, R.
Abstract Title: Five years of therapy with donor and 3rd party derived EBV and CMV specific cytotoxic T cells - Safety after more than 1,000 infusions
Meeting Title: 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
Journal Title: Bone Marrow Transplantation
Volume: 52
Issue: Suppl. 1
Meeting Dates: 2017 Mar 26-29
Meeting Location: Marseille, France
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2017-07-28
Start Page: S58
Language: English
ACCESSION: WOS:000424355300068
PROVIDER: wos
PUBMED: 28751693
DOI: 10.1038/bmt.2017.132
Notes: Meeting Abstract: O080 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Susan E Prockop
    262 Prockop
  2. Craig Steven Sauter
    335 Sauter
  3. Guenther Koehne
    194 Koehne
  4. Aisha Nasreen Hasan
    56 Hasan
  5. Richard O'Reilly
    748 O'Reilly
  6. Parastoo Bahrami Dahi
    302 Dahi
  7. Stephanie Dana Suser
    19 Suser
  8. Victoria Zee Szenes
    16 Szenes